Amplatzer
Device Structural Heart
PDI 00811806011301
General payments
$135,740
Research payments
$158,709
Through program year 2025, $135,740 in general payments and $158,709 in research payments were reported against Amplatzer (Structural Heart).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $45,304 | 361 |
| 2024 | General | $40,533 | 137 |
| 2024 | Research | $92,217 | 36 |
| 2023 | General | $49,904 | 144 |
| 2022 | Research | $66,492 | 45 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
642 general · 81 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.